MCM
ELV icon

Mainstay Capital Management’s Elevance Health ELV Stock Holding History

Mainstay Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-400
Closed -$95K – 440
2018
Q2 		$95K Hold
400
– – 0.07% 119
2018
Q1 		$87K Hold
400
– – 0.07% 122
2017
Q4 		$90K Buy
+400
New +$85.2K 0.07% 132

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mainstay Capital Management's ELV Position: Q3 2018 in Review

Mainstay Capital Management sold out of Elevance Health (ELV) in Q3 2018, closing a stake of 400 shares — an estimated $95K sold.

Mainstay Capital Management first reported a position in ELV in Q4 2017 and held it in 3 quarters. The position peaked at $95K in Q2 2018. 945 funds tracked by Wall St. Rank hold ELV as of Q3 2018.

  • Mainstay Capital Management reported no remaining Elevance Health position as of Q3 2018 after selling out during the quarter.
  • Mainstay Capital Management sold 400 Elevance Health shares in Q3 2018, an estimated $95K.
  • Mainstay Capital Management first reported a position in Elevance Health in Q4 2017 and held it in 3 quarters.
  • Mainstay Capital Management's Elevance Health position peaked at $95K in Q2 2018.
  • 945 funds tracked by Wall St. Rank held Elevance Health as of Q3 2018.

Based on Mainstay Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.